You are here

Article info

Article menu
Download PDFPDF
Clinical science
Outcomes of the Boston type 1 and the Aurolab keratoprosthesis in eyes with limbal stem cell deficiency

Authors

  1. Correspondence to Dr Sayan Basu, Director and D Balasubramanian Chair of Eye Research, Brien Holden Eye Research Centre, L V Prasad Eye Institute, Hyderabad 500034, Telangana, India; sayanbasu{at}lvpei.org
View Full Text

Citation

Shanbhag SS, Senthil S, Mohamed A, et al
Outcomes of the Boston type 1 and the Aurolab keratoprosthesis in eyes with limbal stem cell deficiency
British Journal of Ophthalmology 2021;105:473-478.

Publication history

  • Received March 23, 2020
  • Revised April 28, 2020
  • Accepted May 23, 2020
  • First published June 17, 2020.
Online issue publication 
January 21, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.